Similarities between ankylosing spondylitis and non-radiographic axial SpA, a caveat about positive MRI scans, and the impact of obesity on disease outcomes.
Mark L. Fuerst
Two recent studies underscore the key role of interferon in SLE; a third trial identifies a link between undiagnosed vertebral fractures and organ damage in women with lupus.
The gout-dementia connection, daily medication reminders, and the impact of interleukin-1β inhibition on gout attacks.
Drawbacks of bisphosphonate holidays, bone benefits of the Mediterranean diet, and a new weapon against glucocorticoid-induced osteoporosis.
What’s new: advances in serodiagnostic testing, role of T cell activation in Lyme arthritis, and post-treatment Lyme disease syndrome.
Researchers have set their sights on macrophage activation syndrome, pathways identified in renal cells, and mechanistic target of rapamycin.
Role of Epstein-Barr virus in autoimmune diseases, impact of consensus treatment plans, and the search for biomarkers for juvenile arthritis.
Which type of physical activity best relieves symptoms? What underlies the hypersensitivity of fibromyalgia? Recent studies offer answers.
What’s new: cognitive behavioral therapy can combat opioid misuse, virtual reality provides an escape from pain, and an app helps prevent painful sports injuries.
What's new: reliable outcome measures, overlap in treatment targets, and immune checkpoint inhibitors.